The aim of this review is to summarize present evidence of a causal association of
lipoprotein (a) with risk of ischemic heart disease (IHD). Evidence for causality includes …

Although in vitro studies support a pathophysiologic role for lipoprotein (a)[Lp (a)] in the
development of atherosclerosis, and retrospective studies consistently report that there is a …

The role of lipoprotein (a) in the atherosclerotic process is continually being unraveled, and
many of its potential proatherogenic and prothrombotic features have already been …

Lipoprotein (a) and risk of cardiovascular disease--a systematic review and meta analysis of
prospective studies. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Abstract Purpose of Review This paper reviews the evidence why lipoprotein (a)(Lp (a)) is a
causal risk factor for cardiovascular disease and how high Lp (a) concentrations should be …

Recent published studies have provided increasing evidence that lipoprotein (a)[Lp (a)] may
be a potential causal, genetic, independent risk factor for cardiovascular disease (CVD). Lp …

Although there is highly suggestive evidence for a causal relationship between Lp (a) levels
and CHD, large well prepared 'Mendelian randomization'studies are needed to fully explore …

Background High lipoprotein (a) concentrations present in 10%–20% of the population have
long been linked to increased risk of ischemic cardiovascular disease. It is unclear whether …

Recent data from genetic and epidemiological studies strongly support a causal relationship
between elevated lipoprotein (a)[Lp (a)] concentrations and the development of …

Importance Human genetic studies have indicated that plasma lipoprotein (a)(Lp [a]) is
causally associated with the risk of coronary heart disease (CHD), but randomized trials of …